154 related articles for article (PubMed ID: 19550140)
21. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
Kanduri M; Cahill N; Göransson H; Enström C; Ryan F; Isaksson A; Rosenquist R
Blood; 2010 Jan; 115(2):296-305. PubMed ID: 19897574
[TBL] [Abstract][Full Text] [Related]
22. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of Slit2 in renal cell carcinoma.
Ma WJ; Zhou Y; Lu D; Dong D; Tian XJ; Wen JX; Zhang J
Med Oncol; 2014 Jan; 31(1):768. PubMed ID: 24287947
[TBL] [Abstract][Full Text] [Related]
24. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
Taylor KH; Pena-Hernandez KE; Davis JW; Arthur GL; Duff DJ; Shi H; Rahmatpanah FB; Sjahputera O; Caldwell CW
Cancer Res; 2007 Mar; 67(6):2617-25. PubMed ID: 17363581
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
[TBL] [Abstract][Full Text] [Related]
28. Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer.
Dong R; Yu J; Pu H; Zhang Z; Xu X
J Int Med Res; 2012; 40(2):681-6. PubMed ID: 22613430
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
30. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
[TBL] [Abstract][Full Text] [Related]
31. [Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Salvatore S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):273-8. PubMed ID: 23628015
[TBL] [Abstract][Full Text] [Related]
32. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
[TBL] [Abstract][Full Text] [Related]
33. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
35. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic analysis of childhood acute lymphoblastic leukemia.
Dunwell TL; Hesson LB; Pavlova T; Zabarovska V; Kashuba V; Catchpoole D; Chiaramonte R; Brini AT; Griffiths M; Maher ER; Zabarovsky E; Latif F
Epigenetics; 2009 Apr; 4(3):185-93. PubMed ID: 19430199
[TBL] [Abstract][Full Text] [Related]
37. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
[TBL] [Abstract][Full Text] [Related]
39. Comparative genomics on SLIT1, SLIT2, and SLIT3 orthologs.
Katoh Y; Katoh M
Oncol Rep; 2005 Nov; 14(5):1351-5. PubMed ID: 16211308
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
